Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein

Cell Research

Volumn 15, Issue 1, 2005, Pages 19-23

  Trakul, Nicholas ^a   Rosner, Marsha R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

MAPK; PKC; Raf; RKIP

Indexed keywords

PROTEIN KINASE C; RAF PROTEIN;

ANIMAL; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE COURSE; HUMAN; METABOLISM; METASTASIS; MOUSE; NEOPLASM; NERVE CELL; PATHOLOGY; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; NEOPLASM METASTASIS; NEOPLASMS; NEURONS; PROTEIN KINASE C; RAF KINASES; RATS; SIGNAL TRANSDUCTION;

EID: 19644383643     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290258     Document Type: Short Survey

References (34)

1. Pearson G, Robinson F, Beers Gibson, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001; 22:153-83.
2. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000; 351 Pt 2:289-305.
3. Morrison DK, Cutler RE. The complexity of Raf-1 regulation. Curr Opin Cell Biol 1997; 9:174-9.
4. King AJ, Sun H, Diaz B, et al. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 1998; 396:180-3.
5. Morrison DK, Heidecker G, Rapp UR, Copeland TD. Identification of the major phosphorylation sites of the Raf-1 kinase. J Biol Chem 1993; 268:17309-16.
6. O'Neill E, Kolch W. Conferring specificity on the ubiquitous Raf/MEK signalling pathway. Br J Cancer 2004; 90:283-8.
7. Yip-Schneider MT, Miao W, Lin A, et al. Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. Biochem J 2000; 351:151-9.
8. Bernier I, Tresca JP, Jolles P. Ligand-binding studies with a 23 kDa protein purified from bovine brain cytosol. Biochim Biophys Acta 1998; 871:19-23.
9. Frayne J, Ingram C, Love S, Hall L. Localisation of phosphatidylethanolamine-binding protein in the brain and other tissues of the rat. Cell Tissue Res 1999; 298:415-23.
10. Banfield MJ, Barker JJ, Perry AC, Brady RL. Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure 1998; 6:1245-54.
11. Serre L, Vallee B, Bureaud N, Schoentgen F, Zelwer C. Crystal structure of the phosphatidylethanolamine-binding protein from bovine brain: a novel structural class of phospholipid-binding proteins. Structure 1998; 6:1255-65.
12. Serre L, Pereira de Jesus K, Zelwer C, et al. Crystal structures of YBHB and YBCL from Escherichia coli, two bacterial homologues to a Raf kinase inhibitor protein. J Mol Biol 2001; 310:617-34.
13. Banfield MJ, Barker JJ, Perry AC, Brady RL. Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure 1998; 6:1245-54.
14. Simister PC, Banfield MJ, Brady RL. The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family. Acta Crystallogr D Biol Crystallogr 2002; 58:1077-80.
15. Vallee BS, Tauc P, Brochon JC, et al. Behaviour of bovine phosphatidylethanolamine-binding protein with model membranes. Evidence of affinity for negatively charged membranes. Eur J Biochem 2001; 268:5831-41.
16. Bruun AW, Svendsen I, Sorensen SO, Kielland-Brandt MC, Winther JR. A high-affinity inhibitor of yeast carboxypeptidase Y is encoded by TFS1 and shows homology to a family of lipid binding proteins. Biochemistry 1998; 37:3351-7.
17. Pnueli L, Gutfinger T, Hareven D, et al. Tomato SP-interacting proteins define a conserved signaling system that regulates shoot architecture and flowering. Plant Cell 2001; 13:2687-702.
18. Hengst U, Albrecht H, Hess D, Monard D. The phosphatidylethanolamine- binding protein is the prototype of a novel family of serine protease inhibitors. J Biol Chem 2001; 276:535-40.
19. Ojika K, Mitake S, Tohdoh N, et al. Hippocampal cholinergic neurostimulating peptides (HCNP). Prog Neurobiol 2000; 60:37-83.
20. Tsugu Y, Ojika K, Matsukawa N, et al. High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease. Eur J Neurol 1998; 5:561-9.
21. Matsukawa N, Tooyama I, Kimura H, et al. Increased expression of hippocampal cholinergic neurostimulating peptide-related components and their messenger RNAs in the hippocampus of aged senescence-accelerated mice. Neuroscience 1999; 88:79-92.
22. Saunders PT, McKinnell C, Millar MR, et al. Phosphatidylethanolamine binding protein is an abundant secretory product of haploid testicular germ cells in the rat. Mol Cell Endocrinol 1995; 107:221-30.
23. Hickox DM, Gibbs G, Morrison JR, et al. Identification of a novel testis-specific member of the phosphatidylethanolamine binding protein family, pebp-2. Biol Reprod 2002; 67:917-27.
24. Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999; 401:173-7.
25. Yeung KC, Rose DW, Dhillon AS, et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 2001; 21:7207-17.
26. Kroslak T, Koch T, Kahl E, Hollt V. Human phosphatidylethanolamine- binding protein facilitates heterotrimeric G protein-dependent signaling. J Biol Chem 2001; 276:39772-8.
27. Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003; 426:574-9.
28. Corbit KC, Trakul N, Eves EM, et al. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 2003; 278:13061-8.
29. Fu Z, Smith PC, Zhang L, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003; 95:878-89.
30. Chatterjee D, Bai Y, Wang Z, et al. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 2004; 279:17515-23.
31. Corbit KC, Trakul N, Eves EM, et al. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 2003; 278:13061-8.
32. Dempsey EC, Newton AC, Mochly-Rosen D, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000; 279:L429-38.
33. Corbit KC, Soh JW, Yoshida K, et al. Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol Cell Biol 2000; 20:5392-403.
34. Corbit KC, Foster DA, Rosner MR. Protein kinase Cdelta mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Mol Cell Biol 1999; 19:4209-18.